Drug intelligence / Profile preview

kaihoujian

Development stage
Phase 4
Lead developer
Guizhou Sanli Pharmaceutical
Administration
Topical
01

Overview

Kaihoujian is a traditional Chinese medicine (TCM) formulation originating from Miao medicine and is primarily used as a throat spray for the treatment of acute and chronic pharyngitis, tonsillitis, laryngitis, and related respiratory or oral diseases. The formula consists of several herbal ingredients including Sophorae Tonkinensis Radix et Rhizoma (Sophora tonkinensis), Ardisia crispa root (Ba Zhao Jin Long), Cicadae Periostracum (Chan Tui), and menthol. Its main active constituents include sophocarpine, matrine, bergenin, norbergenin, 11-O-galloylbergenin, anagyrine, calycosin and trifolirhizin. Pharmacological studies suggest that its anti-inflammatory effects are mediated through inhibition of inflammatory mediators such as NO production in macrophages and reduction of white blood cell count as well as inflammatory cytokines like IL-1β and MCP-1. Network pharmacology analyses indicate involvement with targets such as EGFR (epidermal growth factor receptor), MMP9/3/1 (matrix metalloproteinases), PTGS2 (COX-2) via PI3K-AKT/NF-κB/Toll-like receptor signaling pathways[4][7]. Clinical studies have shown efficacy comparable to budesonide for acute laryngitis with particular benefit in sore throat relief[3]. It is widely used in China for both adults and children; pediatric formulations exist under the name "Kaihoujian Throat Spray children's type" or KHJSC[2][6].

Brand names
KaihoujianKai Hou JianKaihoujian sprayKai Hou Jian spray
Other names
KHJKHJSC (for children's type)Kaihoujian Throat Spray
02

Targets

EGFR (Epidermal growth factor receptor)MMP1 (Matrix metalloproteinase-1)MMP3 (Matrix metalloproteinase-3)MMP9 (Matrix metalloproteinase-9)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on kaihoujian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on kaihoujian.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call